6.
Rath H, Herfarth H, Ikeda J, Grenther W, Hamm Jr T, Balish E
. Normal luminal bacteria, especially Bacteroides species, mediate chronic colitis, gastritis, and arthritis in HLA-B27/human beta2 microglobulin transgenic rats. J Clin Invest. 1996; 98(4):945-53.
PMC: 507509.
DOI: 10.1172/JCI118878.
View
7.
Eun C, Mishima Y, Wohlgemuth S, Liu B, Bower M, Carroll I
. Induction of bacterial antigen-specific colitis by a simplified human microbiota consortium in gnotobiotic interleukin-10-/- mice. Infect Immun. 2014; 82(6):2239-46.
PMC: 4019192.
DOI: 10.1128/IAI.01513-13.
View
8.
Bai J, Saha S, Wood M, Chen B, Li J, Dow L
. Serine Supports Epithelial and Immune Cell Function in Colitis. Am J Pathol. 2024; 194(6):927-940.
DOI: 10.1016/j.ajpath.2024.01.021.
View
9.
Montrose D, Nishiguchi R, Basu S, Staab H, Zhou X, Wang H
. Dietary Fructose Alters the Composition, Localization, and Metabolism of Gut Microbiota in Association With Worsening Colitis. Cell Mol Gastroenterol Hepatol. 2020; 11(2):525-550.
PMC: 7797369.
DOI: 10.1016/j.jcmgh.2020.09.008.
View
10.
Islam K, Fukiya S, Hagio M, Fujii N, Ishizuka S, Ooka T
. Bile acid is a host factor that regulates the composition of the cecal microbiota in rats. Gastroenterology. 2011; 141(5):1773-81.
DOI: 10.1053/j.gastro.2011.07.046.
View
11.
Tian Y, Gui W, Koo I, Smith P, Allman E, Nichols R
. The microbiome modulating activity of bile acids. Gut Microbes. 2020; 11(4):979-996.
PMC: 7524280.
DOI: 10.1080/19490976.2020.1732268.
View
12.
Sinha S, Haileselassie Y, Nguyen L, Tropini C, Wang M, Becker L
. Dysbiosis-Induced Secondary Bile Acid Deficiency Promotes Intestinal Inflammation. Cell Host Microbe. 2020; 27(4):659-670.e5.
PMC: 8172352.
DOI: 10.1016/j.chom.2020.01.021.
View
13.
Derrien M, van Baarlen P, Hooiveld G, Norin E, Muller M, de Vos W
. Modulation of Mucosal Immune Response, Tolerance, and Proliferation in Mice Colonized by the Mucin-Degrader Akkermansia muciniphila. Front Microbiol. 2011; 2:166.
PMC: 3153965.
DOI: 10.3389/fmicb.2011.00166.
View
14.
Kuenzig M, Fung S, Marderfeld L, Mak J, Kaplan G, Ng S
. Twenty-first Century Trends in the Global Epidemiology of Pediatric-Onset Inflammatory Bowel Disease: Systematic Review. Gastroenterology. 2022; 162(4):1147-1159.e4.
DOI: 10.1053/j.gastro.2021.12.282.
View
15.
Jantchou P, Morois S, Clavel-Chapelon F, Boutron-Ruault M, Carbonnel F
. Animal protein intake and risk of inflammatory bowel disease: The E3N prospective study. Am J Gastroenterol. 2010; 105(10):2195-201.
DOI: 10.1038/ajg.2010.192.
View
16.
Chassaing B, Srinivasan G, Delgado M, Young A, Gewirtz A, Vijay-Kumar M
. Fecal lipocalin 2, a sensitive and broadly dynamic non-invasive biomarker for intestinal inflammation. PLoS One. 2012; 7(9):e44328.
PMC: 3434182.
DOI: 10.1371/journal.pone.0044328.
View
17.
Sugihara K, Kitamoto S, Saraithong P, Nagao-Kitamoto H, Hoostal M, McCarthy C
. Mucolytic bacteria license pathobionts to acquire host-derived nutrients during dietary nutrient restriction. Cell Rep. 2022; 40(3):111093.
PMC: 10903618.
DOI: 10.1016/j.celrep.2022.111093.
View
18.
Larabi A, Masson H, Baumler A
. Bile acids as modulators of gut microbiota composition and function. Gut Microbes. 2023; 15(1):2172671.
PMC: 9904317.
DOI: 10.1080/19490976.2023.2172671.
View
19.
Wolter M, Steimle A, Parrish A, Zimmer J, Desai M
. Dietary Modulation Alters Susceptibility to Listeria monocytogenes and Salmonella Typhimurium with or without a Gut Microbiota. mSystems. 2021; 6(6):e0071721.
PMC: 8562491.
DOI: 10.1128/mSystems.00717-21.
View
20.
Issokson K, Lee D, Yarur A, Lewis J, Suskind D
. The Role of Diet in Inflammatory Bowel Disease Onset, Disease Management, and Surgical Optimization. Am J Gastroenterol. 2024; 120(1):98-105.
DOI: 10.14309/ajg.0000000000003085.
View